86 related articles for article (PubMed ID: 26352775)
1. Non-clear cell renal cell carcinoma, part 1: histology.
Valenca LB; Hirsch MS; Choueiri TK; Harshman LC
Clin Adv Hematol Oncol; 2015 May; 13(5):308-13. PubMed ID: 26352775
[TBL] [Abstract][Full Text] [Related]
2. Non-clear cell renal cell carcinoma, part 2: therapy.
Valenca LB; Hirsch MS; Choueiri TK; Harshman LC
Clin Adv Hematol Oncol; 2015 Jun; 13(6):383-91. PubMed ID: 26352894
[TBL] [Abstract][Full Text] [Related]
3. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
4. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
5. Non-clear cell advanced kidney cancer: is there a gold standard?
Sánchez P; Calvo E; Durán I
Anticancer Drugs; 2011 Jan; 22 Suppl 1():S9-14. PubMed ID: 21173605
[TBL] [Abstract][Full Text] [Related]
6. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
[TBL] [Abstract][Full Text] [Related]
7. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes.
Wu A; Kunju LP; Cheng L; Shah RB
Histopathology; 2008 Nov; 53(5):533-44. PubMed ID: 18983462
[TBL] [Abstract][Full Text] [Related]
9. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with Xp11.2 translocation in a 7-year-old boy.
Jayasinghe C; Siegler N; Leuschner I; Fleischhack G; Born M; Müller AM
Klin Padiatr; 2010 May; 222(3):187-9. PubMed ID: 20514625
[TBL] [Abstract][Full Text] [Related]
11. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
Parihar A; Tickoo SK; Kumar S; Arora VK
Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
[TBL] [Abstract][Full Text] [Related]
12. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
[TBL] [Abstract][Full Text] [Related]
14. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager.
Sudour-Bonnange H; Leroy X; Chauvet MP; Classe M; Robin PM; Leblond P
Pediatr Blood Cancer; 2014 Sep; 61(9):1698-700. PubMed ID: 24585574
[TBL] [Abstract][Full Text] [Related]
16. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
[TBL] [Abstract][Full Text] [Related]
17. Xp11 translocation renal cell carcinoma.
Ross H; Argani P
Pathology; 2010 Jun; 42(4):369-73. PubMed ID: 20438411
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
19. HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]